BRAF mutations in aberrant crypt foci and hyperplastic polyposis - Wikidata - awgldk - TriplyDB

BRAF mutations in aberrant crypt foci and hyperplastic polyposis

BRAF mutations in aberrant crypt foci and hyperplastic polyposis

http://www.wikidata.org/entity/Q35083792

about

Serrated polyposis: an enigmatic model of colorectal cancer predisposition The molecular characteristics of colonic neoplasms in serrated polyposis: a systematic review and meta-analysis Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancer.Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics Colorectal serrated adenocarcinoma.A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome Prevalence and molecular characterisation of the sessile serrated adenoma in a subset of the Chinese population.Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics Lack of BRAFV600E mutation in stage I and II of colorectal cancer.Serrated pathway colorectal cancer in the population: genetic consideration Serrated adenoma of the colorectum and the DNA-methylator phenotype.Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma Type 1 serrated polyposis represents a predominantly female disease with a high prevalence of dysplastic serrated adenomas, without germline mutation in MUTYH, APC, and PTEN genes.Serrated colon polyps as precursors to colorectal cancer.The molecular biology of gastrointestinal cancer: implications for diagnosis and therapy.Genetic and epigenetic changes in aberrant crypt foci and serrated polyps.Aberrant crypt foci as precursors in colorectal cancer progression.Nomenclature, molecular genetics and clinical significance of the precursor lesions in the serrated polyp pathway of colorectal carcinoma.Sessile serrated adenomas strongly predispose to synchronous serrated polyps in non-syndromic patients.BRAF, a target in melanoma: implications for solid tumor drug development.Serrated polyps: critical precursors to colorectal cancer.Biology and diagnosis of aberrant crypt foci.Serrated polyposis syndrome: molecular, pathological and clinical aspects.Importance of serrated polyps in colorectal carcinogenesis.V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a.Hyperplastic Polyposis Syndrome Identified with a BRAF Mutation A perspective on bi-allelic MUTYH mutations in patients with hyperplastic polyposis syndrome.Topographic, histological and molecular study of aberrant crypt foci identified in human colon in different clinical groups.Light and moderate doses of ethanol in chemical carcinogenesis of the colon in rats.Deletion mutation of BRAF in a serrated adenoma from a patient with familial adenomatous polyposis.Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer.Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps.Molecular classification and genetic pathways in hyperplastic polyposis syndrome Hyperplastic Polyposis Syndrome Is Associated With Cigarette Smoking, Which May Be a Modifiable Risk Factor

P2860

Q24623224-88D81627-9055-4826-ACAB-461ED2731F06 Q26738611-67C6C0DE-B3CF-4DCA-9491-C68C1EAA0143 Q27853224-5247316A-DFE4-4B83-B12D-406A3DFBD2CA Q28081212-65F87EBE-A50F-47A4-B8CE-61E4F09EA700 Q33382510-96188A2E-3411-44D6-8E2A-A31B4FFE4196 Q33520213-5E7C4744-AB89-431B-BB78-53408934D4D3 Q33550512-9197B0F5-00B1-4AAF-9DBF-74B31A6E9180 Q33641289-D8CB1608-5A39-49E5-AC18-556E633F561E Q34597935-846DCE5C-861E-4A60-B120-3CA4DFC3DD93 Q35071477-73CAD4B6-B630-4CB5-902D-40A4E8A302A2 Q35103049-215A7AF5-83AE-4587-9E82-7668CA664772 Q35965705-A3D60C84-D7BF-4BCB-B8D4-46385BCB35EA Q35995540-32971360-7061-4DDA-A677-DFD276BECC41 Q36023417-D99B6765-B7FC-4003-9178-007B87C1B68B Q36244424-45393E98-F98C-4611-9670-DC821AE755BA Q36529734-45AC8510-678A-4089-9633-676D05A04034 Q36719807-91B05389-CA43-46F4-9B94-5CEE8832A92A Q36771915-65C37AF6-4440-417E-AD12-C996EABEAC6D Q36923700-6D50F719-E005-4C5C-B00F-08E518EE6ED0 Q37126768-F07CB16B-0D55-4014-91E4-46C775CEDAE7 Q37214832-89EBE0E6-7A86-4CFB-B62B-DEB6A1AB6037 Q37267219-AB6A5A6B-0E3F-429D-8A2D-BBBD6A898AB4 Q37748915-71FA6869-D21D-4D62-826D-DDD6F49D7A27 Q37772444-153CD15A-FC47-4C81-94AE-9C87E297700D Q37930647-56D5F153-D62F-48D9-9835-D5BEC33BDD46 Q37969808-88042DA8-59D3-473F-B0BC-D688321D0693 Q38015332-17291C57-CDC7-4AED-BD4B-7FCD0C8C4D5C Q38053200-586AFD83-B45E-4E19-9305-CFF1A5AD14A9 Q42059658-71306554-9462-472A-8B38-C552867689E4 Q42145847-F3FB5DAF-9FF4-4564-A8C9-52AF20AEA4CB Q42547654-A79A7A88-D2FC-41D4-9652-1BCE4A06B02A Q49163294-3518DAEF-9EF8-4644-A689-D75118C3E042 Q53223152-5524C0CE-397E-4EE3-8080-057F49006FFF Q53564708-688DAF65-6DDD-4416-92B3-564111C85BDF Q54631097-DADD0386-D4A0-4FD3-A4DC-BF8E16B1EF78 Q54725528-5A7D5BD5-CC1E-4C9B-86BA-9F449EE47AB7 Q57078705-4C2D7349-2D6C-49B3-9182-27B8771428B3 Q57742762-8537E966-A8BA-40B9-B6B0-C6AF46EA05AD

P2860

BRAF mutations in aberrant crypt foci and hyperplastic polyposis

http://www.wikidata.org/entity/Q35083792

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

BRAF mutations in aberrant crypt foci and hyperplastic polyposis

@ast

BRAF mutations in aberrant crypt foci and hyperplastic polyposis

@en

type

label

BRAF mutations in aberrant crypt foci and hyperplastic polyposis

@ast

BRAF mutations in aberrant crypt foci and hyperplastic polyposis

@en

prefLabel

BRAF mutations in aberrant crypt foci and hyperplastic polyposis

@ast

BRAF mutations in aberrant crypt foci and hyperplastic polyposis

@en

P1433

Q35083792-60E4B965-9E1E-4416-8AEE-D548ECEFACAB

P1476

Q35083792-6BD2EA35-CE53-4F19-8EF0-7791B5D821B3

P2093

Q35083792-005F2AEC-5B2F-4BD7-A07D-D687DFD69FBC

Q35083792-153A01A9-D72C-48A0-80AA-F9D3FD2944A8

Q35083792-3388C87D-D6F4-4C57-8D84-3F971EAB4875

Q35083792-533833E2-ED67-4E6A-B8FA-EAA561304AA2

Q35083792-62063385-8AC0-49D0-830E-15E6D402406C

Q35083792-73B580F8-405C-4CEE-A211-21FD1A62A620

Q35083792-BD57998A-BBB5-4252-87CD-680D022FAB7C

Q35083792-EFB2F57E-5596-4C53-91FB-9AABE3F04FDB

Q35083792-F76C66E3-558A-4E8E-9DF6-B2624FC8CF50

Q35083792-F9A21216-A18A-4D61-AFAF-6B77A7822E18

P2860

Q35083792-00865A94-E480-4E81-BC15-4AB03EA99B81

Q35083792-18926340-02D6-4712-9FCB-F0B50E8901D9

Q35083792-27AB50C9-63A9-47BB-B2BD-F887BF301F1B

Q35083792-2C849831-0A3E-4FE9-ADA4-028329BC2F7B

Q35083792-2DFD5C33-A21B-4E89-B5B7-5AB62F154322

Q35083792-34F10E1C-6529-4CDB-88A2-06353F77F85B

Q35083792-38A12DCB-99CA-42E5-A021-EBBFC686D0E1

Q35083792-425C3FC5-2BBD-4A40-BDCE-E6F71E7A63D4

Q35083792-434F6832-8562-460D-BCCA-8CA383D4A441

Q35083792-466DBA3E-3758-4810-9FDC-D14F02D98A11

P304

Q35083792-176C30B9-303F-4E8F-A80E-92B5C232BA27

P31

Q35083792-6B2306BC-DB56-45D1-A189-258D55FA5A0A

P356

Q35083792-343C0E8A-B1F6-4633-AEB5-3836F6ED0C0B

P407

Q35083792-23CDEBBC-B779-4258-9346-DFEED0300C7F

P433

Q35083792-E94578DF-8391-41A0-89C5-04CE955A5F46

P478

Q35083792-FDD019CE-EC92-445C-A34D-6A3A3D94E1C4

P577

Q35083792-117474C8-9904-4E05-B90D-EB5013E5C290

P5875

Q35083792-E51BA2D6-FD4A-49DB-8A33-4429590849A8

P698

Q35083792-19657C34-C0DD-4836-B19D-06C591357AE7

P932

Q35083792-DF14E982-3349-495A-A544-7F46133DA255

P356

S0002-9440(10)62327-9

P1433

The American Journal of Pathology

P1476

BRAF mutations in aberrant crypt foci and hyperplastic polyposis

@en

P2093

Annie On-On Chan

http://www.w3.org/2001/XMLSchema#string

Asif Rashid

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre J Issa

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Morris

http://www.w3.org/2001/XMLSchema#string

Jill A White

http://www.w3.org/2001/XMLSchema#string

Robyn Beach

http://www.w3.org/2001/XMLSchema#string

Russell R Broaddus

http://www.w3.org/2001/XMLSchema#string

Simon Lunagomez

http://www.w3.org/2001/XMLSchema#string

Stanley R Hamilton

http://www.w3.org/2001/XMLSchema#string

Tsung-Teh Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations of the BRAF gene in human cancer

Lessons from hereditary colorectal cancer

The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

Cancer genetics: tumor suppressor meets oncogene.

High frequency of K-ras mutations in human colorectal hyperplastic polyps.

Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas.

Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.

Emerging concepts in colorectal neoplasia.

Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum.

P304

1069-1075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)62327-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7943189

http://www.w3.org/2001/XMLSchema#string

P698

15793287

http://www.w3.org/2001/XMLSchema#string

P932

1602378

http://www.w3.org/2001/XMLSchema#string